Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Tech Bounces Back to Begin Busy Week of Earnings

Published 07/27/2020, 09:15 PM
Updated 07/09/2023, 06:31 AM

Tech returned from the weekend rested and ready to resume its leadership position on Monday, as the sector helped each of the major indices move higher to start a busy week of earnings reports.

It was just like the old days (i.e. a few weeks ago) with the NASDAQ easily outperforming its counterparts. The index jumped 1.67% (or about 173 points) today to 10536.27.

Last week, the NASDAQ wasn’t acting like the market trailblazer that led stocks out of the coronavirus doldrums. The once high-flying tech sector lost significant altitude on fears of being too hot. It was the only index that dropped by more than 1% over the five days.

And each of the FAANGs were down by more than 2% on Thursday, while there was only a tepid rebound on Friday.

Well, they came roaring back on Monday with all of them up by more than 1%, led by Netflix (NASDAQ:NFLX, +3.16%) and Apple (NASDAQ:AAPL, +2.37%).

The market seems excited for all the tech giants reporting in the coming days. On Thursday alone, we’ll be getting the results from Amazon (NASDAQ:AMZN), Apple and Alphabet (NASDAQ:GOOGL) (GOOG) after the bell.

And before that, Advanced Micro Devices (NASDAQ:AMD), which has been taking advantage of rival Intel’s (INTC) troubles, comes to the plate after the bell tomorrow.

And, of course, there will be plenty of non-tech names reporting this week as well, as earnings season really revs up. Some of the names on the horizon include Boeing (NYSE:BA), Pfizer (NYSE:PFE), Exxon Mobil (NYSE:XOM) and Caterpillar (NYSE:CAT), among many others.

Meanwhile, the S&P rose 0.74% to 3239.41, while the Dow advanced 0.43% (or nearly 115 points) to 26,584.77.

Both of these indices snapped three-week winning streaks on Friday, though they were only down 0.3% and 0.7%, respectively, over the five days.

However, this week won’t all be about earnings. Get ready for a lot of news out of Washington, as Congress moves for another coronavirus relief plan as current benefits are days away from expiring.

Senate Republicans released their plan today, which includes reducing the $600 per week being currently offered and another round of direct payments.

Unfortunately, the only things certain in this world are death, taxes and nothing just sails through Congress. We’ll be hearing a lot about this in the coming days as the two sides debate and call each other names.

Let’s just hope they get something done quickly and without too much interruption for the people relying on those funds right now.

While we’re sending out good vibes, let’s also hope that the coronavirus cases decline and progress continues on a vaccine.

This week also includes a Fed meeting, though nothing is really expected to happen. However, it will give Chair Jerome Powell another chance to talk about the Fed doing whatever’s necessary to support the economy during this pandemic, which the market always loves to hear.

So get ready because the last week of July is going to be hectic.

Today's Portfolio Highlights:

Technology Innovators: There’s an implication in the chip space right now that Intel (NASDAQ:INTC) has dropped the ball, which means smaller names have a chance for substantial market share gains. If that’s true, then a company like MaxLinear (MXL) should be a beneficiary. The company is focused more on the communications end of the spectrum, which has been doing pretty well of late. Brian likes the earnings beat in its most recent report and the revenue guidance that was ahead of expectations. Furthermore, rising earnings estimates have made the stock a Zacks Rank #2 (Buy). The editor added MXL on Monday, while also selling the underperforming Blackbaud (NASDAQ:BLKB). Read the full write-up for more on these moves. Meanwhile, this portfolio had one of the top performers on Monday with Tesla (NASDAQ:TSLA, +8.65%).

Surprise Trader: Earnings season may have just started, but the transportation – truck industry has already succeeded a couple times for this portfolio.
So Dave decided to go back to that space for his first buy of the week. ArcBest (NASDAQ:ARCB), which provides freight transportation services and solutions, has beaten earnings estimates for three straight quarters. That includes an impressive surprise of 427% in its most recent report. It currently has an Earnings ESP of 52.94% for the quarter coming before the bell on Wednesday, July 29. The editor added ARCB on Monday with a 10% allocation, while also selling Herc Holdings (NYSE:HRI) for a 2.2% return in about a week. Read the full write-up for more on today’s moves.

Black Box Trader: Half of the portfolio was swapped out in this week's adjustment. The stocks that were sold today included:

• Commercial Metals (CMC, +1.9%)
• Hanesbrands (NYSE:HBI, +1.1%)
• Eldorado Resorts (NASDAQ:ERI) (CZR, +0.24%)
• Robert Half Int'l (NYSE:RHI)
• Nautilus Group (NYSE:NLS)

The new buys that replaced these names were:

• Best Buy (BBY)
• National General Holdings (NASDAQ:NGHC)
• Owens & Minor (NYSE:OMI)
• Summit Materials (NYSE:SUM)
• TRI Pointe Group (TPH)

Read the Black Box Trader’s Guide to learn more about this computer-driven service designed to take the emotion out of investing.

Until Tomorrow,
Jim Giaquinto

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Recommendations from Zacks' Private Portfolios:

Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>


Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.